Both TGR5 siRNA or BRCA1 siRNA significantly exacerbated stroke outcomes and aggravated BBB permeability after MCAO (P < 0.05) (Fig. 6c-f), when compared with scramble siRNA group at 24 h after MCAO. The gene discussed is BRCA1; the disease is stroke disorder.